Sager R. Expression genetics in cancer: Shifting the focus from dna to rna. Proc Natl Acad Sci. 1997; 94(3):952–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dimitrakopoulos CM, Beerenwinkel N. Computational approaches for the identification of cancer genes and pathways. Wiley Interdiscip Rev Syst Biol Med. 2017;9(1).
Leiserson MDM, Blokh D, Sharan R, Raphael BJ. Simultaneous identification of multiple driver pathways in cancer. PLOS Comput Biol. 2013; 9(5):1–15.
Article
Google Scholar
Miller CA, Settle SH, Sulman EP, Aldape KD, Milosavljevic A. Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors. BMC Med Genet. 2011; 4(1):34.
Google Scholar
Vandin F, Upfal E, Raphael BJ. Algorithms for detecting significantly mutated pathways in cancer. J Comput Biol J Comput Mol Cell Biol. 2011; 18(3):507–22.
Article
CAS
Google Scholar
Vandin F, Upfal E, Raphael BJ. De novo discovery of mutated driver pathways in cancer. Genome Res. 2012; 22(2):375–85.
Article
CAS
PubMed
PubMed Central
Google Scholar
Babur O, Gönen M, Aksoy BAA, Schultz N, Ciriello G, Sander C, Demir E. Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations. Genome Biol.2015;16.
Lee Y, Hwang S, Kim J, Park T, Kim Y, Myeong H, Kwon K, Jang C, Noh Y, Kim S. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance. Cancer Genomics Proteomics. 2015; 12(3):153–66.
CAS
PubMed
Google Scholar
Liang P, Pardee AB. Eanalysing differential gene expression in cancer. Nat Rev Cancer. 2003; 3(11):869–76.
Article
CAS
PubMed
Google Scholar
Grützmann R, Boriss H, Ammerpohl O, Lüttges J, Kalthoff H, Schackert HK, Klöppel G, Saeger HD, Pilarsky C. Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes. Oncogene. 2005; 24:5079–88.
Article
PubMed
Google Scholar
Ping Y, Deng Y, Wang L, Zhang H, Zhang Y, Xu C, Zhao H, Fan H, Yu F, Xiao Y, Li X. Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data. Nucleic Acids Res. 2015; 43(4):1997–2007.
Article
CAS
PubMed
PubMed Central
Google Scholar
Network TCGAR. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013; 499(7456):43–9.
Article
Google Scholar
Ruffalo M, Koyutürk M, Sharan R. Network-Based Integration of Disparate Omic Data To Identify “Silent Players” in Cancer. PLoS Comput Biol. 2015; 11(12):1004595.
Article
Google Scholar
Porta-Pardo E, Garcia-Alonso L, Hrabe T, Dopazo J, Godzik A. A pan-cancer catalogue of cancer driver protein interaction interfaces. PLOS Comput Biol. 2015; 11(10):1–18.
Article
Google Scholar
Chen X, Yan C, Zhang X, You Z. Long non-coding rnas and complex diseases: from experimental results to computational models. Brieings in Bioinformatics. 2016;:1–19. doi:10.1093/bib/bbw060.
Chen X, You ZH, Yan GY, Gong DW. Irwrlda: improved random walk with restart for lncrna-disease association prediction. Oncotarget. 2016; 7(36):57919.
Article
PubMed
PubMed Central
Google Scholar
You ZH, Huang ZA, Zhu Z, Yan GY, Li ZW, Wen Z, Chen X. Pbmda: A novel and effective path-based computational model for mirna-disease association prediction. PLOS Comput Biol. 2017; 13(3):1–22.
Article
Google Scholar
Chen X, Yan C, Zhang X, You Z, Huang Y, Yan G. Hgimda: Heterogeneous graph inference for mirna-disease association prediction. Oncotarget. 2016; 7(40):65257.
PubMed
PubMed Central
Google Scholar
Chen X. Katzlda: Katz measure for the lncrna-disease association prediction. Sci Rep.2015;5.
Garcia-Alonso L, Jiménez-Almazán J, Carbonell-Caballero J, Vela-Boza A, Santoyo-López J, Antiñolo G, Dopazo J. The role of the interactome in the maintenance of deleterious variability in human populations. Mol Syst Biol. 2014;10(9).
Leiserson MD, Vandin F, Wu H-TT, Dobson JR, Eldridge JV, Thomas JL, Papoutsaki A, Kim Y, Niu B, McLellan M, Lawrence MS, Gonzalez-Perez A, Tamborero D, Cheng Y, Ryslik GA, Lopez-Bigas N, Getz G, Ding L, Raphael BJ. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat Genet. 2015; 47(2):106–14.
Article
CAS
PubMed
Google Scholar
Kim YA, Cho DY, Dao P, Przytycka TM. Memcover: integrated analysis of mutual exclusivity and functional network reveals dysregulated pathways across multiple cancer types. Bioinformatics. 2015; 31(12):284–92.
Article
Google Scholar
Cho A, Shim JE, Kim E, Supek F, Lehner B, Lee I. Muffinn: cancer gene discovery via network analysis of somatic mutation data. Genome Biol. 2016; 17(1):129.
Article
PubMed
PubMed Central
Google Scholar
Gross AM, Kreisberg JF, Ideker T. Analysis of matched tumor and normal profiles reveals common transcriptional and epigenetic signals shared across cancer types. PLoS One. 2015; 10:0142618.
Google Scholar
Costa GD, Gomig T, Kaviski R, Sousa KS, Kukolj C, Lima RD, Urban CDA, Cavalli I, Ribeiro E. Comparative proteomics of tumor and paired normal breast tissue highlights potential biomarkers in breast cancer. Cancer Genomics Proteomics. 2015; 12(5):251–61.
PubMed
Google Scholar
Gaude E, Frezza C. Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival. Nat Commun. 2012; 7(13041):1–9.
Google Scholar
Wang J, Chen G, Li M, Pan Y. Integration of breast cancer gene signatures based on graph centrality. BMC Syst Biol. 2011; 5(3):10.
Article
Google Scholar
Ramadan E, Alinsaif S, Hassan MR. Network topology measures for identifying disease-gene association in breast cancer. BMC Bioinformatics. 2016; 17(7):274.
Article
PubMed
PubMed Central
Google Scholar
Orchard S, Ammari M, Aranda B, Breuza L, Briganti L, Broackes-Carter F, Campbell NH, Chavali G, Chen C, del-Toro N, Duesbury M, Dumousseau M, Galeota E, Hinz U, Iannuccelli M, Jagannathan S, Jimenez R, Khadake J, Lagreid A, Licata L, Lovering RC, Meldal B, Melidoni AN, Milagros M, Peluso D, Perfetto L, Porras P, Raghunath A, Ricard-Blum S, Roechert B, Stutz A, Tognolli M, van Roey K, Cesareni G, Hermjakob H. The mintact project–intact as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res. 2014; 42(Database issue):358–63.
Article
Google Scholar
Cao M, Pietras CM, Feng X, Doroschak KJ, Schaffner T, Park J, Zhang H, Cowen LJ, Hescott BJ. New directions for diffusion-based network prediction of protein function: incorporating pathways with confidence. Bioinformatics. 2014; 30(12):219–27.
Article
Google Scholar
Wang Y, Qian X. Functional module identification in protein interaction networks by interaction patterns. Bioinformatics. 2014; 30(1):81–93.
Article
PubMed
Google Scholar
Leiserson MD, Vandin F, Wu H-TT, Dobson JR, Eldridge JV, Thomas JL, Papoutsaki A, Kim Y, Niu B, McLellan M, Lawrence MS, Gonzalez-Perez A, Tamborero D, Cheng Y, Ryslik GA, Lopez-Bigas N, Getz G, Ding L, Raphael BJ. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat Genet. 2015; 47(2):106–14.
Article
CAS
PubMed
Google Scholar
Garey MR, Johnson DS. Computers and Intractability: A Guide to the Theory of NP-Completeness.New York: W. H. Freeman & Co.; 1979.
Google Scholar
Sakai S, Togasaki M, Yamazaki K. A note on greedy algorithms for the maximum weighted independent set problem. Discrete Appl Math. 2003; 126(2-3):313–22. doi:10.1016/S0166-218X(02)00205-6.
Article
Google Scholar
Abaka G, Biyikoglu T, Erten C. Campways: constrained alignment framework for the comparative analysis of a pair of metabolic pathways. Bioinformatics. 2013; 29(13):145–53.
Article
Google Scholar
Mehlhorn K, Naher S. Leda: A Platform for Combinatorial and Geometric Computing.New York: Cambridge University Press; 1999.
Google Scholar
Geer LY, Marchler-Bauer A, Geer RC, Han L, He J, He S, Liu C, Shi W, Bryant SH. The NCBI biosystems database. Nucleic Acids Res. 2010; 38(Database-Issue):492–6.
Article
Google Scholar
Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, Cole CG, Ward S, Dawson E, Ponting L, Stefancsik R, Harsha B, Kok CY, Jia M, Jubb H, Sondka Z, Thompson S, De T, Campbell PJ. Cosmic: somatic cancer genetics at high-resolution. Nucleic Acids Res. 2017; 45(D1):777.
Article
Google Scholar
Ashburner M, Ball CA, Blake JA, et al. Gene Ontology: tool for the unification of biology. Nat Genet. 2000; 25(1):25–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Singh R, Xu J, Berger B. Global alignment of multiple protein interaction networks with application to functional orthology detection. Proceedings of the National Academy of Sciences. 2008; 105(35):12763–8.
Article
CAS
Google Scholar
Liao CS, Lu K, Baym M, Singh R, Berger B. Isorankn: spectral methods for global alignment of multiple protein networks. Bioinformatics. 2009; 25(12):253–8.
Article
Google Scholar
Aladağ AE, Erten C. Spinal: Scalable protein interaction network alignment. Bioinformatics. 2013; 29(7):917–24.
Article
PubMed
Google Scholar
Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, Dunn IF, Sjostrom SK, Garraway LA, Weremowicz S, Richardson AL, Greulich H, Stewart CJ, Mulvey LA, Shen RR, Ambrogio L, Hirozane-Kishikawa T, Hill DE, Vidal M, Meyerson M, Grenier JK, Hinkle G, Root DE, Roberts TM, Lander ES, Polyak K, Hahn WC. Integrative genomic approaches identify {IKBKE} as a breast cancer oncogene. Cell. 2007; 129(6):1065–79.
Article
CAS
PubMed
Google Scholar
Bae JS, Park SH, Jamiyandorj U, Kim KM, Noh SJ, Kim JR, Park HJ, Kwon KS, Jung SH, Park HS, Park BH, Lee H, Moon WS, Sylvester KG, Jang KY. Ck2 α/csnk2a1 phosphorylates sirt6 and is involved in the progression of breast carcinoma and predicts shorter survival of diagnosed patients. Am J Pathol. 2016; 186(12):3297–315.
Article
CAS
PubMed
Google Scholar
Kusano S, Yoshimitsu M, Hachiman M, Ikeda M. I-mfa domain proteins specifically interact with htlv-1 tax and repress its transactivating functions. Virology. 2015; 486:219–27.
Article
CAS
PubMed
Google Scholar
Alegre M, Robison R, O’Neill K. Thymidine kinase 1: A universal marker for cancer. Cancer Clin Oncol. 2013; 2(1):159–67.
Google Scholar
van Roosmalen W, Le Dévédec SE, Golani O, Smid M, Pulyakhina I, Timmermans AM, Look MP, Zi D, Pont C, de Graauw M, Naffar-Abu-Amara S, Kirsanova C, Rustici G, Hoen PA, Martens JWM, Foekens JA, Geiger B, van de Water B. Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant. J Clin Investig. 2015; 125(4):1648–64.
Article
PubMed
PubMed Central
Google Scholar
Ellis M, Ding L, Shen D, Luo J, Suman V, Wallis J, Van Tine B, Hoog J, Goiffon R, Goldstein T, Ng S, Lin L, Crowder R, Snider J, Ballman K, Weber J, Chen K, Koboldt D, Kandoth C, Schierding W, McMichael J, Miller C, Lu C, Harris C, McLellan M, Wendl M, Deschryver K, Allred D, Esserman L, Unzeitig G, Margenthaler J, Babiera G, Marcom P, Guenther J, Leitch M, Hunt K, Olson J, Tao Y, Maher C, Fulton L, Fulton R, Harrison M, Oberkfell B, Du F, Demeter R, Vickery T, Elhammali A, Piwnica-Worms H, McDonald S, Watson M, Dooling D, Ota D, Chang L, Bose R, Ley T, Piwnica-Worms D, Stuart J, Wilson R, Mardis E. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature. 2012; 486(7403):353–60.
CAS
PubMed
PubMed Central
Google Scholar
Tate Riegel A, Wellstein A. The potential role of the heparin-binding growth factor pleiotrophin in breast cancer. Breast Cancer Res Treat. 1994; 31(2):309–14.
Article
Google Scholar
Li HH, Zhu H, Liu LS, Huang Y, Guo J, Li J, Sun XP, Chang CX, Wang ZH, Zhaia K. Tumour necrosis factor- α gene polymorphism is associated with metastasis in patients with triple negative breast cancer. Sci Rep. 2015; 5(10244):1–9.
Google Scholar
Zhang H, Fan Y, Ge N, Wang X, Sun W, Mao R, Bu W, Creighton C, Zheng P, Vasudevan S, An L, Yang J, Zhao Y, Zhang H, Li X, Rao P, Leung E, Lu Y, Gray J, Schiff R, Hilsenbeck S, Osborne C, Yang J. Amplification and over-expression of map3k3 gene in human breast cancer promotes formation and survival of breast cancer cells. J Pathol. 2014; 232(1):75–86. doi:10.1002/path.4283.
Article
PubMed
PubMed Central
Google Scholar
Klahan S, Wu M, Hsi E, Huang C, Hou M, Chang W. Computational analysis of mrna expression profiles identifies the itg family and pik3r3 as crucial genes for regulating triple negative breast cancer cell migration. BioMed Res Int. 2014;2014. doi:10.1155/2014/536591.
Kaneko K, IshigamiEmail S, Kijima Y, Funasako Y, Hirata M, Okumura H, Shinchi H, Koriyama C, Ueno S, Yoshinaka H, Natsugoe S. Clinical implication of hla class i expression in breast cancer. Cancer Clin Oncol. 2011; 11(454):1–6.
Google Scholar
Furlan A, Vercamer C, Bouali F, Damour I, Chotteau-Lelievre A, Wernert N, Desbiens X, Pourtier A. Ets-1 controls breast cancer cell balance between invasion and growth. Int J Cancer. 2014; 135(10):2317–28.
Article
CAS
PubMed
Google Scholar
Zhou F, Drabsch Y, Dekker TJ, De Vinuesa AG, Li Y, Hawinkels LJ, Sheppard KA, Goumans MJ, Luwor RB, De Vries CJ, et al.Nuclear receptor nr4a1 promotes breast cancer invasion and metastasis by activating tgf- β signalling. Nat Commun.2014;5.
Kodigepalli KM, Bowers K, Sharp A, Nanjundan M. Roles and regulation of phospholipid scramblases. FEBS Lett. 2015; 589(1):3–14.
Article
CAS
PubMed
Google Scholar
Cayado-Gutiérrez N, Moncalero VL, Rosales EM, Berón W, Salvatierra EE, Alvarez-Olmedo D, Radrizzani M, Ciocca DR. Downregulation of hsp27 (hspb1) in mcf-7 human breast cancer cells induces upregulation of pten. Cell Stress Chaperones. 2013; 18(2):243–9.
Article
PubMed
Google Scholar
Yang S, Chen Y, Sun F, Ni Q, Wang H, Huang Y, Zhang C, Liu K, Wang S, Qiu J, et al.Downregulated pirh2 can decrease the proliferation of breast cancer cells. Arch Med Res. 2016; 47(3):186–95.
Article
CAS
PubMed
Google Scholar
Perkins SM, Bales C, Vladislav T, Althouse S, Miller KD, Sandusky G, Badve S, Nakshatri H. Tfap2c expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis. Breast Cancer Res Treat. 2015; 152(3):519–31.
Article
CAS
PubMed
Google Scholar
Koo GB, Morgan MJ, Lee DG, Kim WJ, Yoon JH, Koo JS, Kim SI, Kim SJ, Son MK, Hong SS, et al.Methylation-dependent loss of rip3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res. 2015; 25(6):707–25.
Article
CAS
PubMed
PubMed Central
Google Scholar